Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 2234

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 1A
Chunk 2234
---
 continue to be available
to us on a timely basis when needed, or that we can find qualified replacements. In addition, if we are unable to effectively manage
our outsourced activities or if the quality, accuracy or quantity of the services provided is compromised for any reason, our pre-clinical
and clinical trials may be extended, delayed or terminated, and we may not be able to obtain, or may be substantially delayed in obtaining,
regulatory approval of our product candidates or otherwise advance our business. There can be no assurance that we will be able to manage
our existing consultants or find other competent outside contractors and consultants on economically reasonable terms, or at all.

If
we are not able to effectively expand our organization by hiring new employees and expanding our groups of consultants and contractors,
we may not be able to successfully implement the tasks necessary to further develop and commercialize our product candidates and, accordingly,
may not achieve our research, development and commercialization goals.

We
may acquire additional technology and complementary businesses in the future. Acquisitions involve many risks, any of which could materially
harm our business, including the diversion of management’s attention from core business concerns, failure to effectively exploit
acquired technologies, failure to successfully integrate the acquired business or realize expected synergies or the loss of key employees
from either our business or the acquired businesses.

The
estimates of market opportunity and forecasts of market growth included in this Annual Report on Form 10-K may prove to be inaccurate,
and even if the markets in which we compete achieve the forecasted growth, our business may not grow at similar rates, or at all.

Market
opportunity estimates and growth forecasts included in this Annual Report on Form 10-K are subject to significant uncertainty and are
based on assumptions and estimates which may not prove to be accurate. The estimates and forecasts included in this Annual Report on
Form 10-K relating to size and expected growth of our target market may prove to be inaccurate. Even if the markets in which we compete
meet the size estimates and growth forecasts included in this Annual Report on Form 10-K, our business may not grow at similar rates,
or at all. Our growth is subject to many factors, including our success in implementing our business strategy, which is subject to many
risks and uncertainties.

107

We
may engage in strategic transactions, which could impact our liquidity, increase our expenses, and present significant distractions to
our management.

We
may consider engaging in a variety of different business arrangements, including merg